相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of Relationship Between Expression of Survivin Protein and Histopathology Diagnosis and Malignancy Severity in Colon Specimen
Amin Jourabchin et al.
JOURNAL OF GASTROINTESTINAL CANCER (2020)
Biological Effects of Licochalcones
Gatta Daniela Maria Pia et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Metformin promotes survivin degradation through AMPK/PKA/GSK-3-axis in non-small cell lung cancer
Zhuang Luo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
Gillianne Gy Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC
Paola Bordi et al.
LUNG CANCER (2019)
Differential effects of adjuvant EGFR tyrosine kinase inhibitors in patients with different stages of non-small-cell lung cancer after radical resection: an updated meta-analysis
Di Lu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Role of Smac, survivin, XIAP, and Omi/HtrA2 proteins in determining the chemotherapeutic response of patients with cervical cancer treated with neoadjuvant chemotherapy
Tianyi Ye et al.
CANCER BIOMARKERS (2019)
Systematic review and network meta-analysis of first-line therapy for advanced EGFR-positive non-small-cell lung cancer
Jacob Franek et al.
FUTURE ONCOLOGY (2019)
Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer
Yucel Baspinar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Licochalcone A Suppresses the Proliferation of Osteosarcoma Cells through Autophagy and ATM-Chk2 Activation
Tai-Shan Shen et al.
MOLECULES (2019)
Natural products in licorice for the therapy of liver diseases: Progress and future opportunities
Xiaojiaoyang Li et al.
PHARMACOLOGICAL RESEARCH (2019)
Licochalcone A inhibits cell proliferation, migration, and invasion through regulating the PI3K/AKT signaling pathway in oral squamous cell carcinoma
Yuli Hao et al.
ONCOTARGETS AND THERAPY (2019)
MicroRNA-218 regulates the chemo-sensitivity of cervical cancer cells through targeting survivin
Minmin Yu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma
Li Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
Tomomi Sanomachi et al.
ANTICANCER RESEARCH (2019)
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
Alessandro Leonetti et al.
BRITISH JOURNAL OF CANCER (2019)
Optimizing outcomes and treatment sequences in EGFR mutation-positive non-small-cell lung cancer: recent updates
Nicolas Girard
FUTURE ONCOLOGY (2019)
Anti-Proliferative and Pro-Apoptotic Effects of Licochalcone A through ROS-Mediated Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells
Su Hyun Hong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
Fengzhi Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor
Guannan Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study
Samaneh Reiszadeh-Jahromi et al.
NEUROCHEMICAL RESEARCH (2019)
Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin
Xinfang Yu et al.
ONCOGENE (2019)
Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?
Sanjal Desai et al.
CURRENT ONCOLOGY REPORTS (2019)
The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models
David Martinez-Garcia et al.
BIOMOLECULES (2019)
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
Camille Mehlman et al.
LUNG CANCER (2019)
Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
Wenbin Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Antisense of survivin inhibits cervical cancer growth in mice
Hui Xu et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway
Wei Li et al.
CANCER MEDICINE (2018)
Acquired resistance in oncogene-addicted non-small-cell lung cancer
Claudio Sini et al.
FUTURE ONCOLOGY (2018)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis
Xianghe Liu et al.
ONCOTARGETS AND THERAPY (2018)
Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells
Wei Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells via p53 Activation and Down-regulation of Survivin
Preeyaporn Plaimee Phiboonchaiyanan et al.
ANTICANCER RESEARCH (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Licochalcone A Inhibits the Proliferation of Human Lung Cancer Cell Lines A549 and H460 by Inducing G2/M Cell Cycle Arrest and ER Stress
Chenyu Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer
Eiki Ichihara et al.
CANCER RESEARCH (2017)
Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis
Liang Duan et al.
BMC CANCER (2016)
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer
Yuqiao Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways
Chung Soo Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
Chunguang Li et al.
PLOS ONE (2012)
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
Uta B. Hofmann et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Licorice and Licochalcone-A Induce Autophagy in LNCaP Prostate Cancer Cells by Suppression of Bcl-2 Expression and the mTOR Pathway
Yi-Te Yo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression
CC Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
